WagnerJ. G., NovakE., LeslieL. G., and MetzlerC. M.: Absorption, Distribution and Elimination of Spectinomycin Dihydrochloride in Man, Int. J. Clin. Pharmacol.1: 261–285, 1968, No. 4.
2.
BurnsJ. J., RoseR. K., ChenkinT., GoldmanA., SchulertA., and BrodieB. B.: The Physiological Disposition of Phenylbutazone (Butazolidin) in Man and a Method for Its Estimation in Biological Material, J. Pharm. Exptl. Therap.109: 346–356, 1953.
3.
BainL. S., JacombR. G., and WynnV.: Parenteral Administration of 6α-Methyl-Prednisolone-21–Acetate: Part II Absorption and Duration of Effect, Ann. Phys. Med.9: 49–54, 1967.
4.
JamesG., and JamesR. C.: “Mathematics Dictionary,” Multilingual Edition, D. Van Nostrand Co., Inc., Princeton, N. J., 1950, pp. 66, 85.
5.
WagnerJ. G., and NorthamJ. I.: Lag Time Before Essentially Constant Urinary Excretion Rate Is Attained, J. Pharm. Sci.57: 994–999, 1968.
6.
LevyG., and MatsuzawaT.: Pharmacokinetics of Salicylamide Elimination in Man, J. Pharmacol. Exptl. Therap.156: 285–293, 1967.
7.
BarrW. H., and RiegelmanS.: “Effect of Capacity Limited Metabolism on Plasma Levels of Free Salicylamide in Man,” presented to the Basic Pharmaceutics Section, A.Ph.A. Academy of Pharmaceutical Sciences, Miami Beach, Florida, May 6, 1968.